http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2002223769-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a6b9594e0fb996ebb00007350ed64a41 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
filingDate | 2001-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bec3ce03a3bb83966af017a5fe3048ae |
publicationDate | 2002-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2002223769-A |
titleOfInvention | Method for predicting side effects of immunosuppressants and primers used therefor |
abstract | (57) [Summary] (Corrected) [PROBLEMS] To provide a means for predicting whether or not a side effect will occur when tacrolimus or cyclosporin is administered as an immunosuppressant, and a primer used therefor. SOLUTION: It is determined whether the 2677th base at the position in the coding region of the cDNA sequence of the human MDR1 gene is guanine, adenine or thymine. MD A forward primer that hybridizes to a region upstream of the 2677th base or a region containing the base at the position in the coding region of the cDNA sequence of the R1 gene, and a region downstream of the base or a region containing the base. And a reverse primer that hybridizes (however, a region where the forward primer and the reverse primer hybridize does not overlap). |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010263810-A |
priorityDate | 2001-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 500.